Apogee Therapeutics' CMO Dambkowski Carl sells 4,600 shares, buys 4,125 shares.
ByAinvest
Wednesday, Feb 4, 2026 8:06 pm ET1min read
APGE--
Apogee Therapeutics, Inc. [APGE] reports that Chief Medical Officer Dambkowski Carl has executed a series of transactions on February 4, 2026. Specifically, he sold 1420 shares at $65.83/share and 1299 shares at $66.85/share, while also buying 4125 shares at $22.86/share. In addition, he sold 100 shares at $67.88/share and 200 shares at $68.94/share. Furthermore, he sold 2481 shares at $64.88/share. Separately, Chief Financial Officer Henderson Jane has sold 792 shares at $65.21/share, 1108 shares at $66.15/share, and 100 shares at $66.89/share on February 2, 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet